Jeil Pharma Holdings Inc (KRX:002620)

South Korea · Delayed Price · Currency is KRW

6,970.00

-240.00 (-3.33%)

Aug 3, 2026, 3:30 PM KST

Jeil Pharma Holdings Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	625,967	657,614	779,822	804,043	792,965	762,568
Revenue Growth	-19.02%	-15.67%	-3.01%	1.40%	3.99%	0.07%
Gross Profit	255,524	253,498	206,521	214,584	180,483	180,507
Operating Income	35,527	38,986	-11,181	20,920	-7,548	-8,975
Net Income	13,441	14,635	-51,159	-16,250	-74,556	-3,482
Earnings Per Share	875.03	953.37	-3333.00	-1059.00	-4857.00	-227.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	83,362	79,312	75,883	59,131	53,403	47,224
Total Debt	168,672	167,369	155,212	214,143	162,616	115,072
Net Cash (Debt)	-85,310	-88,058	-79,329	-155,012	-109,213	-67,848
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5553.88	-5736.24	-5168.22	-10097.73	-7114.36	-4419.76

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	11,896	390.26	4,542	-4,416	-17,256	13,403
Capital Expenditures	-9,427	-8,283	-4,340	-6,223	-15,462	-23,688
Free Cash Flow	2,469	-7,893	202.38	-10,638	-32,717	-10,284
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	40.82%	38.55%	26.48%	26.69%	22.76%	23.67%
Operating Margin	5.68%	5.93%	-1.43%	2.60%	-0.95%	-1.18%
Pretax Margin	6.17%	5.99%	-7.90%	-1.74%	-10.58%	-0.80%
Profit Margin	2.15%	2.23%	-6.56%	-2.02%	-9.40%	-0.46%
FCF Margin	0.39%	-1.20%	0.03%	-1.32%	-4.13%	-1.35%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	50.000	-	-	50.000	50.000	65.000
Dividend Per Share Growth	40.00%	-	-	0%	-23.08%	-7.14%
Dividend Yield	0.69%	-	-	0.43%	0.33%	0.42%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	7.97	8.43	-	-	-	-
P/FCF Ratio	43.34	-	593.17	-	-	-
PS Ratio	0.17	0.19	0.15	0.23	0.30	0.32